Skip to main content
. Author manuscript; available in PMC: 2013 Dec 24.
Published in final edited form as: Ann Surg Oncol. 2008 Apr 9;15(7):10.1245/s10434-008-9890-5. doi: 10.1245/s10434-008-9890-5

FIG. 3.

FIG. 3

Promotion of MADB106 lung tumor cell retention by surgery, and blockade by the combined use of etodolac (e) and propranolol (p). Data are presented as percentage from baseline (control-vehicle) (mean + SEM). Surgery significantly increased LTR (#); each drug significantly attenuated the effect of surgery (*); and their combination abolished it, exhibiting a greater effect than each drug alone (**).